Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503248 | SCV000596847 | uncertain significance | not specified | 2015-08-24 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000674759 | SCV000800151 | uncertain significance | Dyskeratosis congenita, autosomal recessive 5 | 2018-05-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000819303 | SCV000959956 | uncertain significance | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2022-09-23 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 719 of the RTEL1 protein (p.Asp719Asn). This variant is present in population databases (rs781231332, gnomAD 0.04%). This missense change has been observed in individual(s) with dyskeratosis congenita (DC) and pulmonary arteriovenous malformations (PAVMs) (PMID: 27824607). ClinVar contains an entry for this variant (Variation ID: 436588). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001272649 | SCV001454888 | uncertain significance | Dyskeratosis congenita | 2020-09-16 | no assertion criteria provided | clinical testing |